These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2028355)
21. [Insulin signaling and insulin resistance]. Ferré P Therapie; 2007; 62(4):277-84. PubMed ID: 17983553 [TBL] [Abstract][Full Text] [Related]
22. Insights into insulin resistance and type 2 diabetes from knockout mouse models. Kadowaki T J Clin Invest; 2000 Aug; 106(4):459-65. PubMed ID: 10953020 [No Abstract] [Full Text] [Related]
23. Guanine nucleotide binding regulatory proteins in liver from obese humans with and without type II diabetes: evidence for altered "cross-talk" between the insulin receptor and Gi-proteins. Caro JF; Raju MS; Caro M; Lynch CJ; Poulos J; Exton JH; Thakkar JK J Cell Biochem; 1994 Mar; 54(3):309-19. PubMed ID: 8200911 [TBL] [Abstract][Full Text] [Related]
24. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Dokken BB; Sloniger JA; Henriksen EJ Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078 [TBL] [Abstract][Full Text] [Related]
25. Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus. Shao J; Catalano PM; Yamashita H; Ishizuka T; Friedman JE Am J Obstet Gynecol; 2000 Nov; 183(5):1263-70. PubMed ID: 11084576 [TBL] [Abstract][Full Text] [Related]
26. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus. Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625 [TBL] [Abstract][Full Text] [Related]
27. The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus. Leighton B; Cooper GJ Trends Biochem Sci; 1990 Aug; 15(8):295-9. PubMed ID: 2204154 [TBL] [Abstract][Full Text] [Related]
28. IRS-1 regulation in health and disease. Schmitz-Peiffer C; Whitehead JP IUBMB Life; 2003 Jul; 55(7):367-74. PubMed ID: 14584587 [TBL] [Abstract][Full Text] [Related]
29. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus. Baron AD; Kim D; Weyer C Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297 [TBL] [Abstract][Full Text] [Related]
30. [The pathogenesis of type II diabetes mellitus]. Klein HH; Häring HU Internist (Berl); 1990 Mar; 31(3):168-79. PubMed ID: 2187825 [No Abstract] [Full Text] [Related]
31. [Insulin receptors: biochemical and physiopathological aspects]. Freychet P C R Seances Soc Biol Fil; 1984; 178(1):5-17. PubMed ID: 6234973 [No Abstract] [Full Text] [Related]
34. [Insulin resistance. Physiopathological and biochemical aspects]. Freychet P Ann Endocrinol (Paris); 1984; 45(2):107-14. PubMed ID: 6391363 [TBL] [Abstract][Full Text] [Related]
35. 123I-tyrosine-(A14)-insulin: preparation and preliminary clinical studies. Virgolini I; Angelberger P; Banyai M; Knöbl P; Pantev T; Neuhold N; Prager R; Sinzinger H Wien Klin Wochenschr; 1991; 103(21):657-60. PubMed ID: 1771900 [TBL] [Abstract][Full Text] [Related]
36. [Clinical effects of the alterations that emerge in the signaling mechanisms of the insulin receptor]. Hernández-Valencia M Rev Med Inst Mex Seguro Soc; 2006; 44(4):383-8. PubMed ID: 16904045 [TBL] [Abstract][Full Text] [Related]